About us Contact Terms of Use Data Sources Publications FAQ
RASD2 logo

RASD2

GTP-binding protein Rhes

Copy number variation

DiseaseSignal Cell linesGain Cell linesAvg. ampLoss Cell linesAvg. lossNo-signal Cell linesAvg. change
cancer 0 0 0 147 0.88
NS 0 0 0 153 0.90
carcinoma 2 2 1.82 0 550 0.89
haematopoietic_neoplasm 0 0 0 63 0.97
leukaemia 0 0 0 84 0.98
lymphoid_neoplasm 1 0 1 0.43 134 1.00
glioma 1 0 1 0.33 51 0.95
malignant_melanoma 0 0 0 56 1.09
melanoma 0 0 0 43 1.09
glioblastoma 0 0 0 2 0.83

Cell lines

Cell lineSignalCopy numberAvg. genome ploidyAmplificationDiseaseTissue
22Rv-1 No signal 2 2.04 0.98 cancer, NS, carcinoma prostate
5637 No signal 3 2.99 1.00 cancer, carcinoma bladder, urinary_tract
639-V No signal 3 2.41 1.25 cancer, carcinoma bladder, ureter, urinary_tract
647-V No signal 4 2.50 1.60 cancer, carcinoma bladder, urinary_tract
697 No signal 2 1.98 1.01 haematopoietic_neoplasm, leukaemia, lymphoid_neoplasm blood_bone_marrow, haematopoietic_and_lymphoid_tissue
769-P No signal 2 1.97 1.02 carcinoma kidney
786-0 No signal 4 3.82 1.05 cancer, carcinoma kidney
8-MG-BA No signal 2 2.20 0.91 glioma brain, central_nervous_system
8305C No signal 4 3.09 1.29 carcinoma thyroid
8505C No signal 2 3.00 0.67 carcinoma thyroid